Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,071 | 660 | 96.0% |
| Education | $633.54 | 9 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,215 | 68 | $0 (2024) |
| Incyte Corporation | $979.18 | 23 | $0 (2024) |
| Genentech USA, Inc. | $901.70 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $899.81 | 38 | $0 (2024) |
| Seagen Inc. | $782.43 | 29 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $755.65 | 32 | $0 (2024) |
| PFIZER INC. | $692.94 | 40 | $0 (2024) |
| Daiichi Sankyo Inc. | $647.05 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $585.63 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $583.78 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,371 | 185 | Novartis Pharmaceuticals Corporation ($348.62) |
| 2023 | $3,956 | 172 | Genentech USA, Inc. ($278.99) |
| 2022 | $3,460 | 151 | Novartis Pharmaceuticals Corporation ($307.71) |
| 2021 | $3,919 | 161 | Incyte Corporation ($423.54) |
All Payment Transactions
669 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/16/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $130.92 | General |
| Category: Hematology/Oncology | ||||||
| 12/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $12.63 | General |
| Category: Hematology/Oncology | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $135.64 | General |
| Category: HORMONE THERAPY | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.14 | General |
| 11/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: Oncology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.50 | General |
| 11/19/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $25.76 | General |
| 11/14/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.54 | General |
| 11/06/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $10.01 | General |
| 11/06/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $7.84 | General |
| 11/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: Hematology/Oncology | ||||||
| 11/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $2.03 | General |
| Category: Hematology/Oncology | ||||||
| 11/01/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 37 | 39 | $4,875 | $2,271 |
| 2022 | 3 | 72 | 91 | $11,812 | $4,674 |
| 2021 | 3 | 103 | 116 | $15,037 | $6,600 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 39 | $4,875 | $2,271 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 54 | $6,750 | $2,882 | 42.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 25 | $3,550 | $1,129 | 31.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 12 | $1,512 | $662.33 | 43.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 85 | $10,644 | $4,800 | 45.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 19 | $3,493 | $1,353 | 38.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $900.00 | $447.79 | 49.8% |
About Ryan Mobley, NP
Ryan Mobley, NP is a Nurse Practitioner healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720022767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Mobley, NP has received a total of $15,705 in payments from pharmaceutical and medical device companies, with $4,371 received in 2024. These payments were reported across 669 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($15,071).
As a Medicare-enrolled provider, Mobley has provided services to 212 Medicare beneficiaries, totaling 246 services with total Medicare billing of $13,545. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Phoenix, AZ
- Active Since 06/16/2006
- Last Updated 11/17/2022
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1720022767
Products in Payments
- IMBRUVICA (Drug) $669.35
- OPDIVO (Biological) $577.61
- JAKAFI (Drug) $574.77
- KEYTRUDA (Biological) $564.58
- Enhertu (Drug) $412.03
- Alecensa (Biological) $395.65
- ADCETRIS (Biological) $295.10
- KISQALI (Drug) $282.39
- JEVTANA (Drug) $265.69
- Lenvima (Drug) $248.18
- Pomalyst (Drug) $243.68
- OJJAARA (Drug) $240.62
- XTANDI (Drug) $236.06
- VERZENIO (Drug) $222.87
- MONJUVI (Drug) $211.09
- IMFINZI (Biological) $209.03
- VENCLEXTA (Drug) $204.29
- Stivarga (Drug) $203.97
- LIBTAYO (Biological) $201.48
- Nplate (Biological) $194.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Phoenix
Therese Sargent, Anp-Bc, ANP-BC
Nurse Practitioner — Payments: $248,317
Mrs. Edith Gazo, Fnp-C, FNP-C
Nurse Practitioner — Payments: $12,697
Catherine Lynn, Np, NP
Nurse Practitioner — Payments: $12,463
Kristin Staniszewski, Crnp, CRNP
Nurse Practitioner — Payments: $12,243
Ms. Rachael Bennett, Fnp-C, FNP-C
Nurse Practitioner — Payments: $10,197
Amber Senator, Np, NP
Nurse Practitioner — Payments: $8,574